ATH
Click for more information
0.00% 0.4¢ alterity therapeutics limited

Research AD biomarkers to routine diagnostics, page-5

  1. m123456
    1,640 Posts.
    lightbulb Created with Sketch. 143
    clock Created with Sketch.
    15/03/21
    11:26
    Post #: 51768287
    ?? Pbt2 is worth way more than 3c or 4c a share. Why would alteriry sell it? I bet it they did it would be straight back into trials for AD and the dog concerns would disappear
    Last edited by m123456: 15/03/21
    ATH Price at posting: 3.5¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch. 3  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HYT Twiggy Forrest to acquire 40% of native hydrogen explorer – not long after putting Fortescue Future Industries to sleep
right-arrow Created with Sketch.
EBR EBR reaches review milestone for wireless cardiac pacing device
right-arrow Created with Sketch.
HVN Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24
right-arrow Created with Sketch.
TLG Talga expands Prospectus Offer to $9M, banks $18.5M overall since end of financial year
right-arrow Created with Sketch.
NEWS Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip
right-arrow Created with Sketch.
NEWS Results wrap: Wesfarmers, Southern Cross Media, Qantas
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢ 		Change
0.000(0.00%) 		Mkt cap ! $18.62M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $4.887K 1.626M

Buyers (Bids)

No. Vol. Price($)
48 57027004 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 125241201 25
View Market Depth
Last trade - 10.38am 02/09/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.